FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare 0.9% Sodium Chloride Injection Recall

0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcar…

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class II
Reported by FDA
Jul 31, 2019
Recall ID
D-1514-2019
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled 0.9% Sodium Chloride Injection starting Jul 18, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1514-2019 on Jul 31, 2019. Reason: Lack of Assurance of Sterility: Bags have potential to leak. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Bags have potential to leak.

Product description

0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.

Lot numbers, UPCs & expiration codes

Lot #s: P389684; P389742, Exp. 8/31/2020

Where it was sold

Nationwide in the United States and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1514-2019
Classification
Class II
Status
Terminated
Recall initiated
Jul 18, 2019
FDA report date
Jul 31, 2019
Quantity
139,680 Containers
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-1514-2019, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
83340
Address
1 Baxter Pkwy
Code information
Lot #s: P389684; P389742, Exp. 8/31/2020
Postal code
60015-4625
Report date
Jul 31, 2019
Product type
Drugs
Recall number
D-1514-2019
Classification
Class II
Recalling firm
Baxter Healthcare Corporation
Product quantity
139,680 Containers
Termination date
Apr 19, 2021
Reason for recall
Lack of Assurance of Sterility: Bags have potential to leak.
Voluntary / mandated
Voluntary: Firm initiated
Product description
0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.
Distribution pattern
Nationwide in the United States and Puerto Rico.
Recall initiation date
Jul 18, 2019
Initial firm notification
Letter
Center classification date
Jul 23, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1514-2019, published Jul 31, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls